Stock listing
Kamada Ltd.
Selected listing: KMDA · TASE · ILA · IL
Kamada Ltd. (TASE:KMDA), Health Technology. Latest release Oct 6, 2026: Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional…
- Ticker
- TASE:KMDA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TASE
- Currency
- ILA
About Kamada Ltd.
Kamada Ltd. is a public company traded under the ticker KMDA on the American market. Kamada focuses on developing and commercializing innovative therapeutics for various medical conditions.
Latest news from Kamada Ltd.
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
October 6, 2026
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
September 17, 2026
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
August 12, 2026
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
August 5, 2026